Results 201 to 210 of about 6,287 (219)
Some of the next articles are maybe not open access.

Cellular senolytics

Science Translational Medicine, 2020
Repurposing CAR T cells to target senescent cells ameliorates liver fibrosis and extends survival in mice with lung adenocarcinoma.
openaire   +1 more source

Senolytic Drug Development

2020
Cellular senescence is a hallmark of aging because senescent cells (SnCs) accumulate with age and play a causative role in many age-related diseases. Selectively eliminating SnCs has been emerging as a new strategy for treating age-related diseases and extending healthspan. Small molecules that targeting different SnC anti-apoptotic pathways (SCAPs) to
Yonghan He   +2 more
openaire   +1 more source

Gerosuppressive and Senolytic Nutrients

2021
The aging process is intimately regulated by the contribution of interactions between genetic, epigenetic and environmental factors. Every individual is distinguished by a specific personal lifestyle, since conception, that influences the state of health, either leading to the preservation of a good state of health or accelerated aging trajectories ...
openaire   +1 more source

Senolytic potential of Hsp90 inhibitors

Current Chemical Biology, 2020
: Hsp90 chaperone is an encouraging target for the development of novel anticancer agents. The failure of Hsp90 inhibitors to get regulatory approval for the treatment of cancer is hindered due to toxicity, cost involved in their development and formulation issues.
Sayan Dutta Gupta, Cheol Ho Pan
openaire   +1 more source

Senolytic therapy for Alzheimer’s disease

Nature Medicine, 2023
Frank M, Longo, Stephen M, Massa
openaire   +2 more sources

Senolytics in diseases

2023
Gaelle P. Massoud   +5 more
openaire   +1 more source

Immune checkpoint inhibitors as senolytic agents

Cell Research, 2022
Parminder Singh   +2 more
openaire   +2 more sources

Dual Activated Senolytic Prodrug

We present the concept of a precise senolytic prodrug activated in a two-stepmanner, functioning as a chemical AND gate. This design ensures therelease of a cytotoxic agent exclusively in senescent cells thatsimultaneously exhibit two key hallmarks of senescence: increased β-D-galactosidase activity detectable at suboptimal pH ≈6 (the commonly ...
openaire   +1 more source

Home - About - Disclaimer - Privacy